Status:
UNKNOWN
Patient Report Outcome-Reconstruction and Oncoplastic Cohort
Lead Sponsor:
Fudan University
Collaborating Sponsors:
First Affiliated Hospital of Chongqing Medical University
Tianjin Medical University Cancer Institute and Hospital
Conditions:
Patient Reported Outcome Measures
Breast Reconstruction
Eligibility:
FEMALE
18-85 years
Brief Summary
Available studies that focused on patient-reported outcomes (PROs) were mainly from one institution or of small sample size. The variations across hospitals and regions were not fully analyzed. A mult...
Eligibility Criteria
Inclusion
- Breast cancer patients;
- Adult (\>18 years old);
- Female;
- Must undergo breast reconstruction or oncoplastic breast-conserving surgery;
Exclusion
- Younger (\<18 years old);
- Male;
- Stage IV breast cancer patients;
- Refuse to undergo breast reconstruction or oncoplastic breast-conserving surgery.
Key Trial Info
Start Date :
July 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 30 2024
Estimated Enrollment :
10000 Patients enrolled
Trial Details
Trial ID
NCT04030845
Start Date
July 1 2019
End Date
December 30 2024
Last Update
July 25 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shanghai Cancer Center, Fudan University
Shanghai, Shanghai Municipality, China, 200000